Early prediction of response in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) treated with imatinib.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples